Investors Asset Management of Georgia Inc. GA ADV Has $553,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Investors Asset Management of Georgia Inc. GA ADV increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,415 shares of the healthcare conglomerate’s stock after buying an additional 29 shares during the quarter. Investors Asset Management of Georgia Inc. GA ADV’s holdings in UnitedHealth Group were worth $553,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Anfield Capital Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $26,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in UnitedHealth Group in the 2nd quarter valued at approximately $28,000. Activest Wealth Management bought a new position in UnitedHealth Group in the 2nd quarter valued at approximately $29,000. Finally, Ten Capital Wealth Advisors LLC raised its holdings in UnitedHealth Group by 111.6% in the 2nd quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 48 shares during the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of UnitedHealth Group stock in a transaction dated Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 17th. The stock was sold at an average price of $419.00, for a total transaction of $1,047,500.00. The disclosure for this sale can be found here. Insiders sold 82,500 shares of company stock valued at $36,855,125 in the last quarter. Corporate insiders own 0.55% of the company’s stock.

UNH has been the subject of a number of research reports. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price objective for the company in a report on Wednesday, October 27th. SVB Leerink started coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They set an “outperform” rating and a $480.00 target price for the company. Mizuho increased their target price on shares of UnitedHealth Group from $455.00 to $500.00 and gave the company a “buy” rating in a research report on Wednesday, November 10th. Evercore ISI increased their target price on shares of UnitedHealth Group from $360.00 to $480.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. Finally, Royal Bank of Canada increased their target price on shares of UnitedHealth Group from $473.00 to $476.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. One research analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $477.35.

NYSE UNH opened at $450.16 on Thursday. The stock has a market capitalization of $423.98 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a one year low of $320.35 and a one year high of $466.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77. The business’s fifty day moving average is $430.47 and its 200-day moving average is $418.01.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to analyst estimates of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.51 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be given a $1.45 dividend. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s payout ratio is currently 35.98%.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: What is the Book Value of a Share?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.